AddLife AB
STO:ALIF B
AddLife AB
STO:ALIF B
Price:
159.3
SEK
1.85%
Market Cap:
kr18.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AddLife AB
STO:ALIF B
|
SE |
Multiples-Based Value
The Multiples-Based Value of one
ALIF B
stock under the Base Case scenario is
215.91
SEK.
Compared to the current market price of 159.3 SEK,
AddLife AB
is
Undervalued by 26%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALIF B
Multiples-Based Value
215.91
SEK
Undervaluation 26%
Multiples Across Competitors
ALIF B Competitors Multiples
AddLife AB Competitors
AddLife AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
AddLife AB
STO:ALIF B
|
19.1B SEK | 1.9 | 1.9 | 2.1 | 2.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 353.9 | 4 190.9 | 1 200.8 | 2 312.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
193.5B USD | 4.5 | 29.6 | 20.4 | 27.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138.5B USD | 5.8 | 39.1 | 19.8 | 28.8 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
315.4B CNY | 6.9 | 16.4 | 17.1 | 17.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.5B CHF | 5.5 | -129.5 | 17.5 | 27.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.2B USD | 4.8 | 26.5 | 19.5 | 23 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.9B USD | 10.3 | 50.8 | 32.8 | 41.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.2B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.4B USD | 6.9 | 31.8 | 23.5 | 26.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
